Добірка наукової літератури з теми "Permeabilità intestinale"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Permeabilità intestinale".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Permeabilità intestinale"
Bottaccioli, Anna Giulia. "La malattia infiammatoria cronica intestinale: cure integrate in ottica Pnei." PNEI REVIEW, no. 2 (November 2020): 30–40. http://dx.doi.org/10.3280/pnei2020-002004.
Повний текст джерелаBianchi, Alfio Ernesto, Antonio Maggi, and Riccardo Raddino. "Il microbiota intestinale, tra salute e malattia: un vero attore a due facce." CARDIOLOGIA AMBULATORIALE 30, no. 2 (October 14, 2021): 85–91. http://dx.doi.org/10.17473/1971-6818-2021-2-1.
Повний текст джерелаBertossi, Francesca. "Il ruolo del microbiota nell'aumento ponderale associato alla terapia antipsicotica." PNEI REVIEW, no. 2 (November 2022): 108–22. http://dx.doi.org/10.3280/pnei2022-002010.
Повний текст джерелаPabla, D., F. Akhlaghi, H. Zia, Marco Centanni, and Nunzia Brusca. "Incremento della permeabilità intestinale alla levotiroxina sodica mediante acidi grassi a catena lineare studiata in linee di cellule epiteliali MDCK." L'Endocrinologo 12, no. 5 (October 2011): 259–60. http://dx.doi.org/10.1007/bf03344845.
Повний текст джерелаCavin, Jean-Baptiste, Hailey Cuddihey, Wallace K. MacNaughton, and Keith A. Sharkey. "Acute regulation of intestinal ion transport and permeability in response to luminal nutrients: the role of the enteric nervous system." American Journal of Physiology-Gastrointestinal and Liver Physiology 318, no. 2 (February 1, 2020): G254—G264. http://dx.doi.org/10.1152/ajpgi.00186.2019.
Повний текст джерелаDahlgren, David, Maria-Jose Cano-Cebrián, Tobias Olander, Mikael Hedeland, Markus Sjöblom, and Hans Lennernäs. "Regional Intestinal Drug Permeability and Effects of Permeation Enhancers in Rat." Pharmaceutics 12, no. 3 (March 8, 2020): 242. http://dx.doi.org/10.3390/pharmaceutics12030242.
Повний текст джерелаPijls, Kirsten E., Ger H. Koek, Elhaseen E. Elamin, Hanne de Vries, Ad A. M. Masclee, and Daisy M. A. E. Jonkers. "Large intestine permeability is increased in patients with compensated liver cirrhosis." American Journal of Physiology-Gastrointestinal and Liver Physiology 306, no. 2 (January 15, 2014): G147—G153. http://dx.doi.org/10.1152/ajpgi.00330.2013.
Повний текст джерелаMarkovic, Milica, Moran Zur, Sapir Garsiani, Daniel Porat, Sandra Cvijić, Gordon L. Amidon, and Arik Dahan. "The Role of Paracellular Transport in the Intestinal Absorption and Biopharmaceutical Characterization of Minoxidil." Pharmaceutics 14, no. 7 (June 27, 2022): 1360. http://dx.doi.org/10.3390/pharmaceutics14071360.
Повний текст джерелаWillems, D., S. Cadranel, and W. Jacobs. "Measurement of urinary sugars by HPLC in the estimation of intestinal permeability: evaluation in pediatric clinical practice." Clinical Chemistry 39, no. 5 (May 1, 1993): 888–90. http://dx.doi.org/10.1093/clinchem/39.5.888.
Повний текст джерелаOscarsson, Elin, Tim Lindberg, Kathrin S. Zeller, Malin Lindstedt, Daniel Agardh, Åsa Håkansson, and Karolina Östbring. "Changes in Intestinal Permeability Ex Vivo and Immune Cell Activation by Three Commonly Used Emulsifiers." Molecules 25, no. 24 (December 15, 2020): 5943. http://dx.doi.org/10.3390/molecules25245943.
Повний текст джерелаДисертації з теми "Permeabilità intestinale"
Ponce, de Leon Rodriguez Maria del Carmen. "Développement d’un modèle in vitro d’inflammation intestinale par l’utilisation de lignées cellulaires humaines en co-culture pour l’étude des interactionsavec les micro-constituants alimentaires." Thesis, Montpellier, 2019. http://www.theses.fr/2019MONTG009/document.
Повний текст джерелаThe intestinal epithelium, main place of the absorption of (micro)-nutrients is also the first body's defense system. An imbalance in homeostasis can lead to an inflammatory reaction associated with defects in the intestinal barrier and immune function as well as malabsorption of nutrients, as seen in IBD (Inflammatory Bowel Diseases), in micronutrient fortification strategies and noncommunicable diseases (obesity). It is therefore important to find ways of action, for example through diet, to prevent or at least reduce the nutritional and pathological consequences of intestinal inflammation, and to understand the mechanisms involved. Among intestinal models, in vitro cell culture models are increasingly used and allow to evaluate the molecular mechanisms in a simple and reproducible way and to reduce animal experimentation.In this context and in order to study the interaction of dietary bioactive compounds with the intestine in state of inflammation, the first objective of this work was the development of an in vitro model of inflamed intestine combining in co-culture two human intestinal cell lines: Caco-2 TC7 (enterocytes) and HT29-MTX (goblet cells) and an immune cell line of macrophages (THP1). Several inflammation markers were evaluated and we were able to show that the tri-culture model responded to an inflammatory stimulus (LPS / IFNγ), by increasing the production of pro-inflammatory cytokines (TNF-α, IL6 and IL8) and enzymes (INOS and COX2) as well as the expression of their genes. In addition, an increase of epithelial permeability via tight junctions (TJs) alteration has also been demonstrated, as well as overproduction of mucus, which are recognized inflammation characteristics.The second objective was to study the interaction of β-cryptoxanthin (BCX), a lipophilic and antioxidant carotenoid of citrus, with the inflamed model. To solubilize BCX, we used two types of micelles (artificial and physiological) and studied markers of inflammation. Although it appears from the preliminary results that BCX micelles show a tendency to decrease the production of some cytokines (IL6 and IL8), the role of micelle constituents (Tween 40 or bile salts / phospholipids) in the phenomenon observed and in the epithelial permeability remains to be therefore clarified
Weaver, Laurence Trevelyan. "The intestinal permeability of infants." Thesis, University of Cambridge, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.289788.
Повний текст джерелаSmethurst, Paul R. "Small intestinal permeability in man." Thesis, Open University, 1992. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.315531.
Повний текст джерелаLundin, Pål. "Intestinal permeability a parameter of mucosal dysfunction /." Lund : Dept. of Animal Physiology, Lund University, 1997. http://books.google.com/books?id=wuNqAAAAMAAJ.
Повний текст джерелаLang, Mia E. "Intestinal permeability in the irradiated ferret." Thesis, University of Ottawa (Canada), 1991. http://hdl.handle.net/10393/7772.
Повний текст джерелаAnderson, Alexander Douglas Gray. "Measurement of intestinal permeability in surgical patients." Thesis, University of Edinburgh, 2004. http://hdl.handle.net/1842/24575.
Повний текст джерелаSalameh, Emmeline. "Développement d'un modèle murin de dénutrition avec entéropathie et évaluation de molécules d'intérêt permettant de contribuer au rétablissement de la fonction de barrière intestinale." Thesis, Normandie, 2019. http://www.theses.fr/2019NORMR064.
Повний текст джерелаBackground : Severe acute malnutrition (SAM) is a global health issue affecting 17 million children under the age of 5. SAM induces rapid weight loss and is often associated with environmental enteric dysfunction (EED). EED is characterized by intestinal hyperpermeability and inflammation, villus blunting and nutrient malabsorption. EED might, therefore, limit stabilization and re-nutrition protocol efficacy. Objectives : This thesis aimed to develop an undernutrition model with enteropathy to evaluate the effect of a therapeutic milk enriched with nutrients on gut barrier function. Results : During preclinical model development, several approaches were tested: calorie restriction, low-protein diet, use of lipopolysaccharides and indomethacin. Only daily indomethacin gavage during one week in protein-energy undernourished mice induced growth faltering associated with enteropathy. After preclinical model validation, we evaluated the effect of therapeutic milk supplemented with glutamine, leucine, gum arabic and/or selenium-enriched yeast on gut barrier function. Glutamine and leucine induce beneficial effects on gut barrier function. In ourexperimental conditions, therapeutic milk enriched with a combination of glutamine and leucine had a limited impact on this parameter. Gum arabic and selenium-enriched yeasts have prebiotic and probiotic properties on gut barrier function. Therapeutic milk supplemented with gum arabic and selenium-enriched yeast inhibited intestinal inflammation and enhanced specific bacteria abundance such as Faecalibacterium prausnitzii.Conclusion : The studies conducted during this thesis permitted to develop a new model of undernutrition with enteropathy. Therapeutic milk enriched with arabic gum and selenium-enriched yeast triggered beneficial effects on gut barrier function in our preclinical model
Yao, Shengtao. "The effect of denervation on intestinal permeability and function following small intestinal transplantation." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk3/ftp05/mq22692.pdf.
Повний текст джерелаWang, Chuan. "Pathologically and experimentally induced intestinal barrier changes evaluated by permeability measurements." Lund : Dept. of Animal Physiology, Lund University, 1995. http://books.google.com/books?id=ddlqAAAAMAAJ.
Повний текст джерелаBahlouli, Wafa. "Régulation de la perméabilité intestinale au cours du syndrome de l'intestin irritable : role du système ubiquitine-protéasome et impact de l'obésité." Thesis, Normandie, 2019. http://www.theses.fr/2019NORMR047.
Повний текст джерелаIrritable bowel syndrome (IBS) is a multifactorial functional disorder, involving environmental factors (stress and diet for instance), gut-brain-axis dysfunction, micro-inflammation, dysbiosis and an alteration of intestinal permeability. The role of the proteasome in the regulation of the intestinal barrier during IBS has been studied. In addition, these intestinal functional disorders have also been described in patients with obesity. Nevertheless, the mechanisms underlying an association of intestinal functional disorders in the obesity context, remain poorly understood and have therefore been investigated in this thesis. In this study, "IBS-like" mouse models such as water avoidance stress (WAS) and the post-inflammatory (post-TNBS) models, were used to study the impact of proteasome inhibition on the regulation of intestinal permeability. We found that the pharmacological inhibition of the proteasome (with PR-957) or the use of knock-out mice for a subunit of the proteasome (β2i -/-) limit intestinal hyperpermeability occured in IBS-Like models. Moreover, we found that oral supplementation with glutamine also reduces intestinal hyperpermeability, wich, thus, can be considered as a putative nutritional treatment for IBS. A colonic proteomic study of WAS mice and a study of colonic ubiquitoma in IBS patients with diarrheal profiles confirmed the involvement of proteasome in the pathophysiology of IBS. Therefore, the link between obesity and IBS was examined by combining models of obesity (ob/ob genetic and high-fat diet [HFD] models) with WAS model. Only HFD mice displayed enhanced intestinal hyperpermeability and higher plasma corticosterone levels in response to WAS. Further studies suggest that these results, themselve, are independent of leptin, glycaemia and gut microbiota. This study paves new ways of treating patients suffering from IBS, by nutritional intervention via glutamine or by using the proteasome as a therapeutic target. We also suggest a role of diet (high fat) in the development of intestinal functional disorders during obesity
Книги з теми "Permeabilità intestinale"
Ford, Jayne. Non-steroidal anti-inflammatory drugs and intestinal permeability. Manchester: Universityof Manchester, 1994.
Знайти повний текст джерелаSinclair, David Graeme. Changes in pulmonary endothelial and intestinal permeability following cardiopulmonary bypass and in the critically ill. Birmingham: University of Birmingham, 1995.
Знайти повний текст джерелаIntestinal Permeability [Working Title]. IntechOpen, 2020. http://dx.doi.org/10.5772/intechopen.82968.
Повний текст джерелаNaturopath, Case Adams. The Science of Leaky Gut Syndrome: Intestinal Permeability and Digestive Health. Logical Books, 2014.
Знайти повний текст джерелаSingh, Marvin M., and Gerard E. Mullin. Diet, Environmental Chemicals, and the Gut Microbiome. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190490911.003.0006.
Повний текст джерелаBazzan, Anthony J., and Daniel A. Monti. Diet, Gut, and Brain: A New Horizon. Edited by Anthony J. Bazzan and Daniel A. Monti. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190690557.003.0001.
Повний текст джерелаЧастини книг з теми "Permeabilità intestinale"
First, Michael B., Elizabeth Spencer, Elizabeth Spencer, Sander Begeer, Brynn Thomas, Danielle Geno Kent, Maria Fusaro, et al. "Intestinal Permeability Studies." In Encyclopedia of Autism Spectrum Disorders, 1650–52. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1698-3_28.
Повний текст джерелаReynolds, Ann. "Intestinal Permeability Studies." In Encyclopedia of Autism Spectrum Disorders, 2549–51. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-319-91280-6_28.
Повний текст джерелаBjarnason, I., A. Macpherson, and I. S. Menzies. "Intestinal permeability: the basics." In Inflammatory Bowel Disease, 53–70. Dordrecht: Springer Netherlands, 1994. http://dx.doi.org/10.1007/978-94-009-0371-5_6.
Повний текст джерелаWesterbeek, E. A. M., B. Stahl, and R. M. van Elburg. "Human milk and intestinal permeability." In Handbook of dietary and nutritional aspects of human breast milk, 99–116. The Netherlands: Wageningen Academic Publishers, 2013. http://dx.doi.org/10.3920/978-90-8686-764-6_5.
Повний текст джерелаWells, C. L., and S. L. Erlandsen. "Bacterial Translocation: Intestinal Epithelial Permeability." In Update in Intensive Care and Emergency Medicine, 131–49. Berlin, Heidelberg: Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-642-80224-9_9.
Повний текст джерелаPecoraro, C., M. T. Saravo, P. Stanziale, M. M. Balletta, G. Parrilli, and G. Budillon. "Abnormal Intestinal Permeability in IgA Nephropathy." In Current Therapy in Nephrology, 65–67. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-0865-2_17.
Повний текст джерелаOami, Takehiko, and Craig M. Coopersmith. "Measurement of Intestinal Permeability During Sepsis." In Methods in Molecular Biology, 169–75. New York, NY: Springer US, 2021. http://dx.doi.org/10.1007/978-1-0716-1488-4_15.
Повний текст джерелаCaspary, W. F. "Wirkung nichtsteroidaler Antirheumatika auf die intestinale Permeabilität." In Ökosystem Darm VI, 92–102. Berlin, Heidelberg: Springer Berlin Heidelberg, 1994. http://dx.doi.org/10.1007/978-3-642-85187-2_10.
Повний текст джерелаFu, Linglin, Bobby J. Cherayil, Haining Shi, Yanbo Wang, and Yang Zhu. "Intestinal Permeability and Transport of Food Allergens." In Food Allergy, 41–67. Singapore: Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-13-6928-5_3.
Повний текст джерелаMielants, H., E. M. Veys, S. Goemaere, M. De Vos, C. Cuvelier, M. Maertens, and C. Ackerman. "Intestinal mucosal permeability in inflammatory rheumatic diseases." In Side-Effects of Anti-Inflammatory Drugs 3, 80–88. Dordrecht: Springer Netherlands, 1992. http://dx.doi.org/10.1007/978-94-011-2982-4_12.
Повний текст джерелаТези доповідей конференцій з теми "Permeabilità intestinale"
Guliaev, Sergei, Leonid Strizhakov, Sergey Moiseev, Ivan Gmoshinskii, and Vladimir Mazo. "SAT0229 INTESTINAL PERMEABILITY IN IGA-VASCULITIS IN ADULTS." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.3722.
Повний текст джерелаSprooten, Roy T. M., I. Grimbergen, D. Braeken, K. Lenaerts, E. Rutten, E. F. M. Wouters, and G. G. U. Rohde. "Increased small intestinal permeability during severe acute exacerbations of COPD." In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.oa3525.
Повний текст джерелаAubert, P., J. Chevalier, T. Durand, A. Bessard, O. Kelber, H. Abdel-Aziz, and M. Neunlist. "Intestinal permeability induced by psychological stress: Action of STW 5." In GA 2017 – Book of Abstracts. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1608493.
Повний текст джерелаSinghvi, D. G., B. Methe, K. Li, A. Fitch, Y. Zhang, F. C. Sciurba, S. M. Nouraie, A. Morris, and J. M. Bon. "Influence of Smoking on Intestinal Microbiota Composition and Permeability in COPD." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6283.
Повний текст джерелаSeethaler, B., S. Beetz, M. Basrai, A. Schweinlin, J. Walter, M. Laville, NM Delzenne, and SC Bischoff. "Auswirkungen einer Lebensstilveränderung auf die intestinale Permeabilität bei adipösen TeilnehmerInnen eines Gewichtsreduktionsprogramms." In Kongress Ernährung 2020 – Medizin fürs Leben. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1710245.
Повний текст джерелаAubert, P., J. Chevalier, T. Durand, A. Bessard, O. Kelber, H. Aziz-Kalbhenn, and M. Neunlist. "Stress-induced changes in intestinal permeability in mice: Influence of STW 5." In Phytotherapiekongress 2019. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1697324.
Повний текст джерелаBarreto, Mario, Maurizio Simmaco, Luigi Principessa, Alfonso Lostia, Rosanna Zambardi, Susanna Bonafoni, Valentina Negro, Carla Olita, and Maria P. Villa. "Asthma And Intestinal Permeability In Children: Role Of Age, Symptoms And Allergen Sensitization." In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a6250.
Повний текст джерелаAubert, P., J. Chevalier, T. Durand, A. Bessard, O. Kelber, H. Abdel-Aziz, and M. Neunlist. "STW 5 prevents stress-induced changes in intestinal permeability in mice in-vivo." In GA 2017 – Book of Abstracts. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1608490.
Повний текст джерелаLuneva, O. E. "Food supplement “carrageenan” and its effect on the organism." In VIII Information school of a young scientist. Central Scientific Library of the Urals Branch of the Russian Academy of Sciences, 2020. http://dx.doi.org/10.32460/ishmu-2020-8-0014.
Повний текст джерелаNogueira, Fábio Dias, Ana Klara Rodrigues Alves, Barbara Beatriz Lira da Silva, Ana Kamila Rodrigues Alves, Marlilia Moura Coelho Sousa, Ana Karla Rodrigues Alves, Wanderson da Silva Nery, Breno Carvalho de Almeida, Flávia Dias Nogueira, and Leiz Maria Costa Véras. "The autistic spectrum disorder and its relation to intestinal dysbiosis." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.283.
Повний текст джерела